Status:
UNKNOWN
Pre-operative MRI of Esophagus Cancer
Lead Sponsor:
Dromain Clarisse
Conditions:
Esophagus Cancer
Diagnoses Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The role of MRI in the management of esophageal cancer remains unclear and poorly studied. Recent technical advances suggest that MRI may become a powerful technique for the initial assessment of esop...
Detailed Description
The study will be proppsed consecutively to all patients with a histologically proven diagnosis of esophageal cancer. An MRI examination including morphological sequences (without and with injection ...
Eligibility Criteria
Inclusion
- Any pathologically proven oesophagus cancer
Exclusion
- MRI contraindication
- Pregnant women
- cervical esophagus cancer
Key Trial Info
Start Date :
October 2 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 30 2019
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03347630
Start Date
October 2 2017
End Date
March 30 2019
Last Update
November 21 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHUV
Lausanne, Canton of Vaud, Switzerland, 1011